Botox Market Research Report Information By Application (Therapeutics (Chronic Migraine, Spasticity, Overactive Bladder, Cervical Dystonia, Blepharospasm, Others) and Aesthetics), By Type (Botulinum Toxin Type A and Botulinum Toxin Type B), By End-User (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others), By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL BOTOX MARKET, BY APPLICATION

6.1. Overview

6.2. Therapeutics

6.2.1. Chronic Migraine

6.2.2. Spasticity

6.2.3. Overactive Bladder

6.2.4. Cervical Dystonia

6.2.5. Blepharospasm

6.2.6. Others

6.3. Aesthetics

7. GLOBAL BOTOX MARKET, BY TYPE

7.1. Overview

7.2. Botulinum Toxin Type A

7.3. Botulinum Toxin Type B

8. GLOBAL BOTOX MARKET, BY END-USER

8.1. Overview

8.2. Specialty & Dermatology Clinics

8.3. Hospitals & Clinics

8.4. Others

9. GLOBAL BOTOX MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Botox Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Botox Market,

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2022

10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES

11.1. AbbVie Inc. (U.S.)

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Lanzhou Institute of Biological Products Co., Ltd. (China)

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Ipsen Pharma (France)

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Merz Pharma (Germany)

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Medytox (South Korea)

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. GALDERMA (Switzerland)

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. HUGEL, Inc. (South Korea)

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Evolus, Inc. (U.S.)

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Revance Therapeutics, Inc. (U.S.)

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Supernus Pharmaceuticals, Inc. (U.S.)

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Products Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL BOTOX MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL BOTOX MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 5 GLOBAL BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 9 US: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 10 US: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 11 US: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 12 CANADA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 13 CANADA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 14 CANADA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 1 EUROPE: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 2 EUROPE: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 3 EUROPE: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 4 GERMANY: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5 GERMANY: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 6 GERMANY: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 7 FRANCE: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 8 FRANCE: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 9 FRANCE: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 10 ITALY: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 11 ITALY: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 12 ITALY: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 13 SPAIN: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 14 SPAIN: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 15 SPAIN: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 16 UK: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 17 UK: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 18 UK: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 19 REST OF EUROPE: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 20 REST OF EUROPE: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 21 REST OF EUROPE: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 22 ASIA-PACIFIC: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 23 ASIA-PACIFIC: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 24 ASIA-PACIFIC: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 25 JAPAN: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 26 JAPAN: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 27 JAPAN: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 28 CHINA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 29 CHINA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 30 CHINA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 31 INDIA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 32 INDIA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 33 INDIA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 34 AUSTRALIA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 35 AUSTRALIA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 36 AUSTRALIA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 37 SOUTH KOREA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 38 SOUTH KOREA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 39 SOUTH KOREA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 40 REST OF ASIA-PACIFIC: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 41 REST OF ASIA-PACIFIC: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 42 REST OF ASIA-PACIFIC: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 43 REST OF THE WORLD: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 44 REST OF THE WORLD: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 45 REST OF THE WORLD: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 46 MIDDLE EAST: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 47 MIDDLE EAST: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 48 MIDDLE EAST: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 49 AFRICA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 50 AFRICA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 51 AFRICA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

TABLE 52 LATIN AMERICA: BOTOX MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 53 LATIN AMERICA: BOTOX MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 54 LATIN AMERICA: BOTOX MARKET, BY END-USER, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BOTOX MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BOTOX MARKET

FIGURE 4 GLOBAL BOTOX MARKET, SHARE (%), BY APPLICATION, 2021

FIGURE 5 GLOBAL BOTOX MARKET, SHARE (%), BY TYPE, 2021

FIGURE 6 GLOBAL BOTOX MARKET, SHARE (%), BY END-USER, 2021

FIGURE 7 GLOBAL BOTOX MARKET, SHARE (%), BY REGION, 2021

FIGURE 8 NORTH AMERICA: BOTOX MARKET, SHARE (%), BY REGION, 2021

FIGURE 9 EUROPE: BOTOX MARKET, SHARE (%), BY REGION, 2021

FIGURE 10 ASIA-PACIFIC: BOTOX MARKET, SHARE (%), BY REGION, 2021

FIGURE 11 REST OF THE WORLD: BOTOX MARKET, SHARE (%), BY REGION, 2021

FIGURE 12 GLOBAL BOTOX MARKET: COMPANY SHARE ANALYSIS, 2021 (%)

FIGURE 13 ABBVIE INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 ABBVIE INC. (U.S.): SWOT ANALYSIS

FIGURE 15 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD. (CHINA): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD. (CHINA): SWOT ANALYSIS

FIGURE 17 IPSEN PHARMA (FRANCE): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 IPSEN PHARMA (FRANCE): SWOT ANALYSIS

FIGURE 19 MERZ PHARMA (GERMANY): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 MERZ PHARMA (GERMANY): SWOT ANALYSIS

FIGURE 21 MEDYTOX (SOUTH KOREA): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 MEDYTOX (SOUTH KOREA): SWOT ANALYSIS

FIGURE 23 GALDERMA (SWITZERLAND): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 GALDERMA (SWITZERLAND): SWOT ANALYSIS

FIGURE 25 HUGEL, INC. (SOUTH KOREA): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 HUGEL, INC. (SOUTH KOREA): SWOT ANALYSIS

FIGURE 27 EVOLUS, INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 EVOLUS, INC. (U.S.): SWOT ANALYSIS

FIGURE 29 REVANCE THERAPEUTICS, INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 REVANCE THERAPEUTICS, INC. (U.S.): SWOT ANALYSIS

FIGURE 31 SUPERNUS PHARMACEUTICALS, INC. (U.S.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 SUPERNUS PHARMACEUTICALS, INC. (U.S.): SWOT ANALYSIS